A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD)

Koh K, Nogami K, Kakuda H, Okimoto Y, Hino M, Tanigawara Y, Li Z, Suzuki C, Terashio S, Ueda H, Ohga S

Journal of Blood Medicine 2026, 17:535025

Published Date: 13 March 2026